Daniel Lafkas is a Principal Scientist at Roche, focused on drug discovery for respiratory diseases such as COPD, asthma, and cystic fibrosis. With over 7 years of experience in the field, they have led various projects through different stages of the drug development pipeline, emphasizing inflammatory diseases and novel restorative approaches. Prior to their current role at Roche, they served as a Scientist and Senior Scientist at Genentech from 2016 to 2022 and completed a PhD at the Marie Curie Research Institute from 2008 to 2012. Daniel earned a Bachelor’s degree in Biology with a focus on Cell and Molecular Biology from Ethnikon kai Kapodistriakon Panepistimion Athinon.
This person is not in the org chart
This person is not in any teams
This person is not in any offices